MARTIN-LEWIS AGAR W/REDUCED VANCOMYCIN C0226

Culture Media, For Isolation Of Pathogenic Neisseria

GIBCO LABORATORIES LIFE TECHNOLOGIES, INC.

The following data is part of a premarket notification filed by Gibco Laboratories Life Technologies, Inc. with the FDA for Martin-lewis Agar W/reduced Vancomycin C0226.

Pre-market Notification Details

Device IDK871541
510k NumberK871541
Device Name:MARTIN-LEWIS AGAR W/REDUCED VANCOMYCIN C0226
ClassificationCulture Media, For Isolation Of Pathogenic Neisseria
Applicant GIBCO LABORATORIES LIFE TECHNOLOGIES, INC. 2801 INDUSTRIAL DR. Madison,  WI  53713
ContactGregg G Burmeister
CorrespondentGregg G Burmeister
GIBCO LABORATORIES LIFE TECHNOLOGIES, INC. 2801 INDUSTRIAL DR. Madison,  WI  53713
Product CodeJTY  
CFR Regulation Number866.2410 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1987-04-20
Decision Date1987-04-29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.